ASBMR 2012

October 2012 - Entera presents the "Pharmacokinetics of Novel Oral PTH 1-34 Dosage Form (Tablet) in Rodents" for its Osteoporosis drug at the annual meeting of ASBMR (The American Society of Bone and Mineral Research) in Minneapolis, Minnesota. PTH 1-34 administered orally in rodents demonstrates consistent enteral absorption with a PK profile characterized by a rapid Tmax and rapid elimination simulating the desired PTH profile required for its anabolic effect.

pdfSee poster